Soligenix, Inc.
SNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000812796
No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Soligenix, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −2 vs. Q4 2023
- Shares held
- 239.1K
- −139.6K (−36.9%) vs. Q4 2023
- Total value
- $143.0K
- −$143.5K (−50.1%) vs. Q4 2023
- New holders
- 5
- 5 more added
- Sold out
- 7
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $369.6K |
| Q1 2026 | 15 | $307.4K |
| Q4 2025 | 19 | $600.0K |
| Q3 2025 | 23 | $1.61M |
| Q2 2025 | 15 | $248.2K |
| Q1 2025 | 11 | $313.1K |
| Q4 2024 | 10 | $82.8K |
| Q3 2024 | 7 | $262.4K |
| Q2 2024 | 11 | $259.1K |
| Q1 2024 | 18 | $143.0K |
| Q4 2023 | 20 | $286.5K |
| Q3 2023 | 19 | $500.2K |
| Q2 2023 | 20 | $1.02M |
| Q1 2023 | 16 | $195.2K |
| Q4 2022 | 36 | $1.37M |
| Q3 2022 | 30 | $1.35M |
| Q2 2022 | 28 | $1.91M |
| Q1 2022 | 33 | $2.38M |
| Q4 2021 | 28 | $2.24M |
| Q3 2021 | 34 | $4.35M |
| Q2 2021 | 34 | $4.59M |
| Q1 2021 | 35 | $5.22M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Soligenix, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 56,799 | $34.1K | 0.00% | +6,603+13.2% | Added |
| Vanguard Group Inc | 50,865 | $30.5K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 30,000 | $18.0K | 0.00% | +30,000 | New |
| Warberg Asset Management LLC | 24,500 | $14.7K | 0.00% | +4,500+22.5% | Added |
| First Wilshire Securities Management Inc | 23,334 | $14.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 12,731 | $7.64K | 0.00% | +997+8.5% | Added |
| HRT Financial LP | 12,518 | $7.00K | 0.00% | +12,518 | New |
| Two Sigma Securities, LLC | 11,435 | $6.86K | 0.00% | +11,435 | New |
| Tower Research Capital LLC (TRC) | 6,967 | $4.18K | 0.00% | +192+2.8% | Added |
| Plante Moran Financial Advisors, LLC | 4,778 | $2.87K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,594 | $2.16K | 0.00% | −7−0.2% | Reduced |
| UBS Group AG | 1,429 | $857 | 0.00% | +1,429 | New |
| Wells Fargo & Company | 81 | $49 | 0.00% | +5+6.6% | Added |
| Advisor Group Holdings, Inc. | 53 | $32 | 0.00% | 00.0% | Unchanged |
| Brown Brothers Harriman & Co | 34 | $20 | 0.00% | +34 | New |
| Bank of America Corp | 19 | $12 | 0.00% | 00.0% | Unchanged |
| Albion Financial Group | 5 | $3 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 3 | $2 | 0.00% | −45−93.8% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −92,792−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −80,651−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,743−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −211−100.0% | Sold out |
| Scarborough Advisors, LLC | 0 | $0 | 0.00% | −62−100.0% | Sold out |